Trials / Completed
CompletedNCT01279915
A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects
Phase I Study of ASP0456 - A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study in Non-elderly Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending dose of ASP0456 in non-elderly healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP0456 | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2011-01-20
- Last updated
- 2011-01-20
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01279915. Inclusion in this directory is not an endorsement.